Shares in Dexcom (NSDQ:DXCM) soared today after the medical device maker topped expectations on Wall Street with its third quarter results.
The San Diego, Calif.-based company posted a net loss of -$2 million, or -2¢ per share, on sales of $184.6 million for the 3 months ended Sept. 30, for sales growth of 24% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Dexcom beats earnings estimate by 12 cents in Q3 appeared first on MassDevice.
from MassDevice http://ift.tt/2h7rPJp
Cap comentari:
Publica un comentari a l'entrada